Last updated: 15 June 2019 at 5:27am EST

John Wesolowski Net Worth




The estimated Net Worth of John Wesolowski is at least $155 ezer dollars as of 26 February 2019. John Wesolowski owns over 282 units of Perrigo plc stock worth over $67,547 and over the last 8 years John sold PRGO stock worth over $87,845.

John Wesolowski PRGO stock SEC Form 4 insiders trading

John has made over 11 trades of the Perrigo plc stock since 2016, according to the Form 4 filled with the SEC. Most recently John exercised 282 units of PRGO stock worth $13,618 on 26 February 2019.

The largest trade John's ever made was exercising 1,033 units of Perrigo plc stock on 1 March 2018 worth over $82,196. On average, John trades about 290 units every 50 days since 2016. As of 26 February 2019 John still owns at least 2,527 units of Perrigo plc stock.

You can see the complete history of John Wesolowski stock trades at the bottom of the page.



What's John Wesolowski's mailing address?

John's mailing address filed with the SEC is C/O PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN, MI, 49010.

Insiders trading at Perrigo plc

Over the last 11 years, insiders at Perrigo plc have traded over $21,020,805 worth of Perrigo plc stock and bought 592,512 units worth $38,708,035 . The most active insiders traders include Jeffrey C Smith, Gary M Cohen és Joseph C Papa. On average, Perrigo plc executives and independent directors trade stock every 11 days with the average trade being worth of $156,424. The most recent stock trade was executed by Ronald Craig Janish on 26 August 2024, trading 13,000 units of PRGO stock currently worth $382,200.



What does Perrigo plc do?

perrigo company plc, a top five global over-the-counter (otc) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. from its beginnings in 1887 as a packager of generic home remedies, perrigo, headquartered in ireland, has grown to become the world's largest manufacturer of otc products and supplier of infant formulas for the store brand market. the company is also a leading provider of branded otc products, generic extended topical prescription products and receives royalties from multiple sclerosis drug tysabri®. perrigo provides “quality affordable healthcare products®” across a wide variety of product categories and geographies primarily in north america, europe, and australia, as well as other key markets including israel and china. visit perrigo online at (http://www.perrigo.com).



Complete history of John Wesolowski stock trades at Perrigo plc

Az érdekelt
Trans.
Tranzakció
Teljes ár
John Wesolowski
EVP és President Rx
Opció Gyakorlat $13,618
26 Feb 2019
John Wesolowski
EVP és President Rx
Opció Gyakorlat $35,070
29 Jun 2018
John Wesolowski
EVP és President Rx
Opció Gyakorlat $82,196
1 Mar 2018
John Wesolowski
EVP és President Rx
Opció Gyakorlat $28,026
15 Dec 2017
John Wesolowski
EVP és President Rx
Megvenni $60,060
14 Dec 2017
John Wesolowski
EVP és President Rx
Eladás $37,391
7 Dec 2017
John Wesolowski
EVP és President Rx
Eladás $33,834
28 Nov 2017
John Wesolowski
EVP és President Rx
Eladás $16,621
7 Sep 2017
John Wesolowski
EVP és President Rx
Opció Gyakorlat $10,396
21 Aug 2017
John Wesolowski
EVP és President Rx
Opció Gyakorlat $26,848
15 Dec 2016
John Wesolowski
EVP és President Rx
Opció Gyakorlat $26,848
15 Dec 2016


Perrigo plc executives and stock owners

Perrigo plc executives and other stock owners filed with the SEC include: